This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Battery powered and other implants that could cause problems during the cremation of human remains

Authoring team

Battery powered and other implants that could cause problems during the cremation of human remains

  • pacemakers

  • implantable Cardioverter Defibrillators (ICDs)

  • cardiac resynchronization therapy devices (CRTDs)

  • implantable loop recorders

  • ventricular assist devices (VADs): Left ventricular assist devices (LVADs), Right ventricular assist devices (RVADs), or Biventricular assist devices BiVADs)

  • implantable drug pumps including intrathecal pumps

  • neurostimulators (including for pain & Functional Electrical Stimulation)

  • bone growth stimulators

  • hydrocephalus programmable shunts

  • any other battery powered implant

  • fixion nails

  • dental mercury amalgam

  • brachytherapy to the prostate, i.e. radioactive iodine-125 seeds (advice from the Department of Radiology and Urology at the Royal London Free and Whittington Hospitals states that iodine 125 seeds produce radiation for about one year, therefore if death occurs within 12 months following implantation the seeds should be removed)

Reference:

  • Huntingdon NHS Primary Care Trust (2005). Policy for death verification and certification, cremation formas and coroners referrals
  • Ministry of Justince.The Cremation (England and Wales) Regulations 2008.

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.